Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport in Post-Surgical Neuralgia
NCT03663101Phase 2Completed
- Sponsor
- Ipsen
- Start
- Oct 2018
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of abobotulinumtoxinA in chronic scar pain, sponsored by Ipsen. Started Oct 2018; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
chronic scar pain
Beyond the preview
Go deeper on NCT03663101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03663101.